Investigational anti-interleukin-6 monoclonal antibody achieves durable inflammatory biomarker reductions

https://www.news-medical.net/news/20260829/Investigational-anti-interleukin-6-monoclonal-antibody-achieves-durable-inflammatory-biomarker-reductions.aspx The investigational anti-interleukin-6 (IL-6) monoclonal antibody pacibekitug produced sustained reductions in inflammation-related biomarkers through six months in patients with chronic kidney disease and elevated inflammatory risk associated with heart disease.